Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
New Microbes New Infect ; 34: 100652, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32071727

ABSTRACT

Testing for vector-borne pathogens in livestock is largely reliant upon blood and tissue. The role of biopsy samples remains poorly explored for detecting tick-borne bacteria in animals. In a 2-year survey, animals of veterinary importance from farms throughout the northern part of Greece were routinely checked for the presence of biopsy samples. Where detected, either a portion or a biopsy was collected together with whole blood samples and any ticks at the site of the biopsy sample. Molecular testing was carried out by real-time PCR targeting the internal transcribed spacer gene of Bartonella species. A total of 68 samples (28 blood samples, 28 biopsy samples and 12 ticks (nine Rhipicephalus bursa and three Rhipicephalus turanicus)) were collected from goats (64 samples) and cattle (four samples). Eight (11.8%) of the 68 samples were positive for Bartonella species. Of the biopsy and whole blood samples, four (14.3%) of each type were positive for Bartonella species. None of the ticks tested positive for Bartonella species. All pairs of positive biopsy samples/whole blood samples originated from the same animals. Positive samples were identified as Bartonella vinsonii subsp. arupensis. Although many more samples from a much wider spectrum of animal species is required before concluding upon the merit of biopsy samples in the study of tick-borne diseases, the significance of our finding warrants further study, both for clinical consequences in small ruminants and for those humans who are farming infected animals.

2.
Eur J Intern Med ; 23(4): 368-73, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22560388

ABSTRACT

BACKGROUND: Τhe importance of angiogenesis in malignancies' growth is well recognized. CD105 (Endoglin), a proliferation-associated glycoprotein, is a powerful marker of neovascularization. Elevated amounts of soluble CD105 (sCD105) have been identified in selected solid tumors. The aim of the study was to estimate circulating levels of sCD105 and soluble transforming growth factor-ß(1) (sTGF-ß(1)), in multiple myeloma (MM) patients, to determine their significance in tumor progression and to investigate the correlation between sCD105 and markers of disease activity. METHODS: We studied 50 newly diagnosed MM patients. Twenty-five of them were also investigated in plateauphase. Twenty patients with monoclonal gammopathy of undetermined significance (MGUS) were enrolled in this study. As control group 28 healthy persons were studied. We determined sCD105, sTGF-ß(1) and interleukin-6 (IL-6) in the serum, Ki-67 proliferation index (Ki-67 PI) expression and microvascular density(MVD) in bone marrow with immunohistochemistry. RESULTS: The mean concentrations of sCD105 and IL-6 were higher in MM and MGUS patients compared to controls, whereas serum levels of sTGF-ß(1) were lower in MM patients compared to MGUS patients and controls. sCD105 levels, were significantly different among disease stages, with higher values in advanced stages. It was found that sCD105 correlated with Ki-67 PI, MVD and IL-6. CONCLUSIONS: CD105 seems to play an important role in angiogenesis and tumor progression. Circulating levels of sCD105 could detect patients with more advanced disease and might help in evaluating the response to treatment.


Subject(s)
Antigens, CD/blood , Multiple Myeloma/blood , Neovascularization, Physiologic/physiology , Receptors, Cell Surface/blood , Transforming Growth Factor beta1/blood , ADP-ribosyl Cyclase 1/metabolism , Adult , Aged , Aged, 80 and over , Disease Progression , Endoglin , Female , Humans , Immunohistochemistry , Interleukin-6/blood , Ki-67 Antigen/metabolism , Male , Middle Aged
3.
J Comp Pathol ; 144(1): 82-5, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20591440

ABSTRACT

A 10-month-old ram with fever, inappetence and haemorrhagic diathesis had petechiae and ecchymoses at various body sites and was infested by ticks. Haematological examination revealed pancytopenia, while serum biochemistry indicated hepatic dysfunction. Blood smears were negative for Ehrlichia spp. and other haemoparasites. Paired sera revealed infection by Anaplasma phagocytophilum, but testing by polymerase chain reaction was negative. Treatment with oxytetracycline was effective. This is the first reported clinical case of ovine anaplasmosis in Greece caused by A. phagocytophilum.


Subject(s)
Anaplasma phagocytophilum/isolation & purification , Ehrlichiosis/veterinary , Hemorrhagic Disorders/veterinary , Sheep Diseases/pathology , Tick Infestations/veterinary , Anaplasma phagocytophilum/physiology , Animals , Anti-Bacterial Agents/therapeutic use , Ehrlichiosis/complications , Ehrlichiosis/drug therapy , Ehrlichiosis/pathology , Hemorrhagic Disorders/drug therapy , Hemorrhagic Disorders/microbiology , Hemorrhagic Disorders/pathology , Male , Oxytetracycline/therapeutic use , Sheep , Sheep Diseases/drug therapy , Sheep Diseases/microbiology , Tick Infestations/pathology , Ticks/parasitology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL